Recovering from a difficult first quarter, radiotherapy developer Eckert & Ziegler produced a slight increase in sales in its second quarter.
For the period (end-1 June), Eckert & Ziegler had total sales of 28.8 million euros, up 1% from the 28.6 million euros reported in the second quarter of 2012. Net income decreased slightly, however, to 3 million euros, compared with 3.2 million euros a year ago.
Eckert & Ziegler forecasts that 2013 sales will reach approximately 125 million euros, with net earnings after taxes and minority interests of 2.15 euros per-share.
